OBJECTIVES: The sonic hedgehog (Shh) pathway has an established role in pancreatic cancer (pancreatic adenocarcinoma [PDAC]). We tested whether magnetic resonance imaging measures of vascular volume fraction (VVF) using magnetic iron oxide nanoparticles are sensitive to the antiangiogenic effect of targeted Shh therapies in a PDAC xenograft model. METHODS: Pancreatic adenocarcinoma xenograft lines were subcutaneously implanted into nude mice (n = 19 samples within 4 groups). Therapies were targeted to 3 loci of the Shh signaling pathway (anti-Shh antibody, cyclopamine, or forskolin). Magnetic resonance imaging (4.7-T Bruker Pharmascan) was performed (after 1 week of intraperitoneal therapy) before and after intravenous injection of MION-47. Vascular volume fraction was quantified as DeltaR2 (from multicontrast T2 sequences) and normalized to an assumed VVF in muscle of 3%. Linear regression compared VVF to histological indices including microvessel density (MVD), viable gland density (VGD), and proliferative index (PI). RESULTS: In response to anti-Hh treatment, tumors showed a decrease in VGD, PI, MVD, and VVF compared with controls (P < 0.001). Vascular volume fraction was compared with histological indicators of response: PI (R2 = 0.88; P < 0.05), VGD (R2 = 0.87; P< 0.05), and MVD (R2 = 0.85; P < 0.05). CONCLUSIONS: Magnetic resonance imaging VVF using magnetic iron oxide nanoparticles may serve as a noninvasive measure of biological response to Shh PDAC therapy with easy translation to the clinic.
OBJECTIVES: The sonic hedgehog (Shh) pathway has an established role in pancreatic cancer (pancreatic adenocarcinoma [PDAC]). We tested whether magnetic resonance imaging measures of vascular volume fraction (VVF) using magnetic iron oxide nanoparticles are sensitive to the antiangiogenic effect of targeted Shh therapies in a PDAC xenograft model. METHODS:Pancreatic adenocarcinoma xenograft lines were subcutaneously implanted into nude mice (n = 19 samples within 4 groups). Therapies were targeted to 3 loci of the Shh signaling pathway (anti-Shh antibody, cyclopamine, or forskolin). Magnetic resonance imaging (4.7-T Bruker Pharmascan) was performed (after 1 week of intraperitoneal therapy) before and after intravenous injection of MION-47. Vascular volume fraction was quantified as DeltaR2 (from multicontrast T2 sequences) and normalized to an assumed VVF in muscle of 3%. Linear regression compared VVF to histological indices including microvessel density (MVD), viable gland density (VGD), and proliferative index (PI). RESULTS: In response to anti-Hh treatment, tumors showed a decrease in VGD, PI, MVD, and VVF compared with controls (P < 0.001). Vascular volume fraction was compared with histological indicators of response: PI (R2 = 0.88; P < 0.05), VGD (R2 = 0.87; P< 0.05), and MVD (R2 = 0.85; P < 0.05). CONCLUSIONS: Magnetic resonance imaging VVF using magnetic iron oxide nanoparticles may serve as a noninvasive measure of biological response to ShhPDAC therapy with easy translation to the clinic.
Authors: Jennifer P Morton; Michelle E Mongeau; David S Klimstra; John P Morris; Yie Chia Lee; Yoshiya Kawaguchi; Christopher V E Wright; Matthias Hebrok; Brian C Lewis Journal: Proc Natl Acad Sci U S A Date: 2007-03-19 Impact factor: 11.205
Authors: H Friess; J Ding; J Kleeff; L Fenkell; J A Rosinski; A Guweidhi; J F Reidhaar-Olson; M Korc; J Hammer; M W Büchler Journal: Cell Mol Life Sci Date: 2003-06 Impact factor: 9.261
Authors: Johanna A Joyce; Pirjo Laakkonen; Michele Bernasconi; Gabriele Bergers; Erkki Ruoslahti; Douglas Hanahan Journal: Cancer Cell Date: 2003-11 Impact factor: 31.743
Authors: Christoph Bremer; Mona Mustafa; Alex Bogdanov; Vasilis Ntziachristos; Alexander Petrovsky; Ralph Weissleder Journal: Radiology Date: 2003-01 Impact factor: 11.105
Authors: Sarah P Thayer; Marina Pasca di Magliano; Patrick W Heiser; Corinne M Nielsen; Drucilla J Roberts; Gregory Y Lauwers; Yan Ping Qi; Stephan Gysin; Carlos Fernández-del Castillo; Vijay Yajnik; Bozena Antoniu; Martin McMahon; Andrew L Warshaw; Matthias Hebrok Journal: Nature Date: 2003-09-14 Impact factor: 49.962
Authors: Paul J Grippo; Palamadai N Venkatasubramanian; Richard H Knop; Daniel M Heiferman; Gheorghe Iordanescu; Laleh G Melstrom; Kevin Adrian; Morgan R Barron; David J Bentrem; Alice M Wyrwicz Journal: Am J Pathol Date: 2011-05-31 Impact factor: 4.307
Authors: Alexander R Guimaraes; Robert Ross; Jose L Figuereido; Peter Waterman; Ralph Weissleder Journal: Mol Imaging Biol Date: 2011-04 Impact factor: 3.488
Authors: Gerda B Toth; Csanad G Varallyay; Andrea Horvath; Mustafa R Bashir; Peter L Choyke; Heike E Daldrup-Link; Edit Dosa; John Paul Finn; Seymur Gahramanov; Mukesh Harisinghani; Iain Macdougall; Alexander Neuwelt; Shreyas S Vasanawala; Prakash Ambady; Ramon Barajas; Justin S Cetas; Jeremy Ciporen; Thomas J DeLoughery; Nancy D Doolittle; Rongwei Fu; John Grinstead; Alexander R Guimaraes; Bronwyn E Hamilton; Xin Li; Heather L McConnell; Leslie L Muldoon; Gary Nesbit; Joao P Netto; David Petterson; William D Rooney; Daniel Schwartz; Laszlo Szidonya; Edward A Neuwelt Journal: Kidney Int Date: 2017-04-20 Impact factor: 10.612
Authors: Binh T T Pham; Emily K Colvin; Nguyen T H Pham; Byung J Kim; Emily S Fuller; Elizabeth A Moon; Raphael Barbey; Samuel Yuen; Barry H Rickman; Nicole S Bryce; Stephanie Bickley; Marcel Tanudji; Stephen K Jones; Viive M Howell; Brian S Hawkett Journal: Int J Mol Sci Date: 2018-01-10 Impact factor: 5.923
Authors: Ronald Jh Borra; Hoon-Sung Cho; Spencer L Bowen; Ulrike Attenberger; Grae Arabasz; Ciprian Catana; Lee Josephson; Bruce R Rosen; Alexander R Guimaraes; Jacob M Hooker Journal: EJNMMI Phys Date: 2015-02-26